The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials

BACKGROUND: Recently, there have been several randomized clinical trials (RCTs) conducted to evaluate the efficacy and safety of metformin plus standard treatment in inoperable cancer patients. Our meta-analysis aimed to assess the efficacy of metformin in combination with standard treatment in inop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Zhonghua, Qu, Bicheng, Huang, Xuanzhang, Song, Yongxi, Gao, Peng, Shi, Jinxin, Zhou, Cen, Wang, Zhenning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723600/
https://www.ncbi.nlm.nih.gov/pubmed/33313149
http://dx.doi.org/10.21037/atm-20-4441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723600/
https://www.ncbi.nlm.nih.gov/pubmed/33313149
http://dx.doi.org/10.21037/atm-20-4441

Ejemplares similares